Anne-Marie C. Dingemans MD, PhD is a pulmonologist and a professor of thoracic oncology. Since September 2019 she is staff member at the department of pulmonary medicine at Erasmus Medical Center, Rotterdam, The Netherlands. Between 2004 and 2019 she was appointed as a staff member at the department of pulmonary medicine at Maastricht University Medical Center+. She received her medical degree at Maastricht University in 1994 and subsequently her PhD at VU Medical Center Amsterdam in 2000 for laboratory research on resistance to chemotherapy in lung cancer. She performed her training for respiratory physician at VU Medical Center in Amsterdam and Leiden University Medical Center. Currently she is involved in translational research in lung cancer, with special interest in neuroendocrine lung tumors, driver mutations and oligometastatic disease.

Since January 2021 she is chair of the EORTC lung cancer group. She was involved in the EORTC initiatives to develop a consensus definition on synchronous oligometastatic NSCLC and a consensus definition of resectability of stage III NSCLC. She is the lead-author of the revised ESMO guideline on SCLC. She is member of IASLC, AACR, ASCO, ERS, ESMO and ETOP. She is associate editor of the Journal of Thoracic Oncology and editorial board member of the International IASLC Lung Cancer News. She has (co)-authored more than 300 publications and book chapters.